First Header Logo Second Header Logo

Connection

Samuel Lentz to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications Samuel Lentz has written about Cystadenocarcinoma, Serous.
Samuel Lentz
Connection Strength
0.015
Cystadenocarcinoma, Serous
  1. Young RC, Brady MF, Nieberg RK, Long HJ, Mayer AR, Lentz SS, Hurteau J, Alberts DS. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study. J Clin Oncol. 2003 Dec 01; 21(23):4350-5.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.